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Abstract
Gambiense human African trypanosomiasis (gHAT) is a parasitic,
vector-borne neglected tropical disease that has historically affected
populations across West and Central Africa and can result in death if
untreated. Following from the success of recent intervention programmes
against gHAT, the World Health Organization (WHO) has defined a 2030
goal of global elimination of transmission (EOT). The key proposed
indicator to measure achievement of the goal is to have zero reported
cases. Results of previous mathematical modelling and quantitative
analyses are brought together to explore both the implications of the
proposed indicator and the feasibility of achieving the WHO goal.
 
Whilst the indicator of zero case reporting is clear and measurable, it is an
imperfect proxy for EOT and could arise either before or after EOT is
achieved. Lagging reporting of infection and imperfect diagnostic specificity
could result in case reporting after EOT, whereas the converse could be
true due to underreporting, lack of coverage, and cryptic human and animal
reservoirs. At the village-scale, the WHO recommendation of continuing
active screening until there are three years of zero cases yields a high
probability of local EOT, but extrapolating this result to larger spatial scales
is complex.
 
Predictive modelling of gHAT has consistently found that EOT by 2030 is
unlikely across key endemic regions if current medical-only strategies are
not bolstered by improved coverage, reduced time to detection and/or
complementary vector control.  Unfortunately, projected costs for strategies
expected to meet EOT are high in the short term and strategies that are
cost-effective in reducing burden are unlikely to result in EOT by 2030.
Future modelling work should aim to provide predictions while taking into
account uncertainties in stochastic dynamics and infection reservoirs, as
well as assessment of multiple spatial scales, reactive strategies, and
measurable proxies of EOT.
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Disclaimer
The views expressed in this article are those of the authors. 
The opinions expressed herein are those of the authors and do 
not necessarily reflect the views of the World Health Organi-
zation. Publication in Gates Open Research does not imply 
endorsement by the Gates Foundation.
Background
Gambiense human African trypanosomiasis (gHAT, sleeping 
sickness) is an infection caused by the parasite Trypanosoma 
brucei gambiense, spread through blood-meal feeding by 
tsetse in West and Central Africa. Disease symptoms caused by 
gHAT generally progress over multiple years. Stage 1 disease is 
defined as the time before the parasite crosses the blood-brain 
barrier, with symptoms such as headache and fever, whereas 
stage 2 involves neurological symptoms and typically death 
if left untreated. Fortunately, there are a variety of tools avail-
able to assist in the control of gHAT and these have been effec-
tive at reducing the burden of gHAT from 37,385 cases in 1998 
to 953 cases in 20181. The primary intervention against gHAT 
is large-scale, test-confirm-and-treat strategies with diagno-
sis and confirmation performed by mobile teams in at-risk 
villages, followed by hospitalisation for treatment; 56% of 
detected cases in 2016 were diagnosed in this way2. The rest of 
cases are identified through passive surveillance (self-presenta-
tion) in fixed health facilities. There are additional options to 
reduce transmission by targeting the tsetse vector directly, which 
has been implemented successfully in several regions, but is 
currently a non-standard component of intervention strategies 
in most areas.
Previously, the World Health Organization (WHO) roadmap 
set a target of elimination as a public health problem (EPHP) 
for gHAT by 20202, which has been redefined as (a) hav-
ing fewer than 2000 globally reported cases and (b) at least a 
90% reduction in areas reporting >1 case per 10,000 people 
over a five-year period (2016–2020) compared to a 2000–2004 
baseline (Table 1)3. It is complex to determine yet whether 
the second indicator will be met without a detailed analysis of 
global data; however, 1419 cases were reported in 2017 and 
953 were reported in 2018, suggesting that the first indica-
tor should have been not only met but greatly surpassed. The 
subsequent WHO goal is global elimination of transmission 
(EOT) by 2030 (Table 1)4. Achievement of EOT for gHAT 
would not only represent a huge stand-alone accomplish-
ment but would place gHAT amongst the very select group of 
infections for which, through deliberate intervention, global 
EOT has already been achieved (smallpox and rinderpest) 
or may be met by 2030 (e.g. Guinea worm and polio).
Predictive, mechanistic modelling is a data-driven approach to 
explore the feasibility of reaching the WHO goals, taking into 
account the known biology of infection but also representing 
uncertainty in all processes. Recent mathematical modelling 
by the NTD Modelling Consortium and collaborators - 
including groups from the Institute for Disease Modeling, 
the Swiss Tropical and Public Health Institute, University of 
Warwick and Yale University - has provided quantitative 
perspectives on the challenges of reaching and the likelihood 
of achieving both the 2020 and 2030 WHO goals for gHAT. 
The following sections outline some of the key model findings 
that are of direct relevance to the 2030 EOT goal.
Modelling insights from strategies previously conducted
In the last two decades, the predominant strategy against gHAT 
was medical only, comprising active screening and passive 
Table 1. Summary of modelling perspectives of the WHO goals for gambiense human African 
trypanosomiasis (gHAT).
Current WHO Goal (2020 Goal) Elimination as a public health problem (EPHP). Indicators: (a) <2000 cases 
globally; and (b) >90% reduction in areas reporting >1 case/10,000 people in 
2016–2020 compared to 2000–2004.
Proposed WHO Goal (2030 
Goal)
Elimination of transmission (EOT). Indicators: (a) zero reported cases; (b) 90% 
reduction in high and moderate risk areas relative to 2020 baseline; and (c) 
>50% and >95% of at-risk populations <1 hour and <5 hours from a health 
facility with gHAT diagnostics, respectively.
Is the new target technically 
feasible under the current 
disease strategy?
The target is likely to be technically feasible using existing tools but would 
require a step change in the level of surveillance and the use of additional 
controls (such as door-to-door screening or vector control) in persistent 
regions.
If not, what is required to 
achieve the target?
New rapid diagnostic tests, together with 2030 health facility targets, will help 
case detection. New drugs should improve compliance and ease of treatment. 
Novel targeted surveillance approaches may be needed close to elimination.
Are current tools able to reliably 
measure the target?
Yes - existing diagnostics are likely sufficient. However, the indicator of zero 
reported cases does not imply that the goal of EOT has been reached.
What are the biggest 
unknowns?
Prevalence of infection in regions that have never had active surveillance. 
The role of asymptomatic infections and animal reservoirs as elimination is 
approached.
What are the biggest risks? Lack of participation in surveillance at a range of scales. Inability to screen and 
treat due to conflict. Reduction in controls, particularly passive surveillance, 
once zero cases are reported locally.
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surveillance followed by treatment. Current medical-based 
gHAT control strategies are working well in reducing incidence2 
and modelling indicates they are also reducing underlying 
transmission5,6. Shortening time to detection and treatment 
of cases further reduces morbidity and subsequent onward 
transmission7. Modelling indicates that, in Uganda and South 
Sudan, passive surveillance reduced transmission by 30-50% 
during the 1990s and 2000s; strengthening these systems in 
gHAT endemic regions could therefore have great potential8. 
Staged gHAT case data (differentiating between stage 1 and 
stage 2 cases) can provide substantial information on the 
effectiveness of, and changes in, the passive surveillance 
system; for example, improvement in time to detection in 
former Bandundu province in the Democratic Republic of the 
Congo (DRC) is reflected in a greater proportion of stage 1 
cases9. 
Despite these successes, controls can be disrupted by con-
flict or other events; notably, the Ebola epidemic in West Africa 
resulted in temporary cessation of medial activities10. Further-
more, in higher endemicity settings or regions with little screen-
ing, the current medical-only interventions are predicted to be 
insufficient for achieving EOT by 2030 (e.g. in several health 
zones in Bandundu, DRC, EOT is predicted to be realised 
after 2050)11–13. In these settings - assuming scale up of vector 
control (VC) is feasible and the substantial (>80%) reduction 
in tsetse density14,15 can be reproduced widely - supplementing 
medical interventions with VC is predicted to be cost-effective at 
relatively low willingness-to-pay (WTP) thresholds in high-risk 
areas13, and to lead to EOT in much shorter timescales 
(1–6 years instead of >30 years in some settings)11,12.
What are the practical implications of the elimination 
of transmission goal?
The WHO 2030 goal for gHAT is EOT globally, with the key 
proposed indicator of achieving zero reported cases (Table 1). 
Other proposed indicators relate to sustaining coverage 
of passive surveillance.
Measuring the target
In the long term, reaching EOT will lead to zero detected 
cases; however, the two objectives are not equivalent - it is pos-
sible either that zero case detections could occur without 
EOT or, conversely, that gHAT detections could be observed 
even after EOT.
EOT before zero reporting. Achieving EOT may not immedi-
ately lead to zero detected cases as there is often a long period 
between infection and detection (several years is typical16, 
although in extreme cases this could be decades17). As EOT is 
approached, the choice of confirmatory diagnostics becomes 
increasingly important as imperfect test specificity, even cur-
rent algorithms with ~99.9% specificity, can lead to false 
positive cases. As we approach the 2030 goal, more rigor-
ous methodologies (e.g. the laboratory-based trypanolysis 
test with 100% specificity18) should help to circumnavigate 
this problem.
Zero reporting but not EOT. Achieving zero detected cases 
does not mean that there is EOT for numerous reasons. The 
first possibility is that screening does not identify all remain-
ing infections at peri-elimination. Only some of the population 
at risk is regularly screened; modelling5,6,9 suggests that some 
high-risk individuals (~20% of the population) may not attend 
active screenings and data show that not all settlements in high-
risk areas are screened annually (around 50% of villages in a 
high-endemicity region of DRC were screened in any given 
year4,19). Coverage may improve with mini mobile teams 
(screening otherwise inaccessible villages) or door-to-door 
screening (likely increasing the number of high-risk people 
participating), but pockets of infection could still be missed. 
Furthermore, large areas of DRC (Figure 1), South Sudan 
and Central African Republic with potential transmission are 
not regularly screened due to regional conflicts. Secondly, 
even where there is a functional health system, there is a high 
probability of underreporting; models for Bandundu, DRC, sug-
gest that only around 20% of gHAT cases that escape active 
detection are identified by passive detection (Model W in Rock 
et al.9), corresponding to ~63% of all infections being 
unreported.
Models can be used in order to explore the predictive power 
of one or more years of zero detected cases in estimating the 
Figure 1. Geographic availability of gambiense human African 
trypanosomiases (gHAT) data across the Democratic Republic 
of the Congo. Colours represent numbers of reported cases in 
health zones from the last five years of data set. Health zones that 
never (2000–2016) report cases or active screening are coloured 
grey, whilst zones with <5% mean active screening coverage 
(during 2012–2016) are shown with black dots. This figure has been 
adapted from data presented in Franco et al.1 under a CC-BY 4.0 
license and with permission from Dr Erick Mwamba Miaka, director 
of the National HAT Control Programme (PNLTHA) of the Democratic 
Republic of the Congo.
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likelihood of EOT. A stochastic village-level model (replay-
ing active screening from 2000-16 for 559 settlements in Yasa 
Bonga & Mosango, Bandundu, DRC) focussed on detecting 
zero cases under active screening. This model strongly indicates 
that three or more consecutive rounds of finding zero cases is 
sufficient to reach >90% positive predictive value (PPV) of 
local EOT across typical village sizes and where screenings 
that achieve <10% coverage were ignored (Figure 2)19. There 
is higher certainty of EOT in smaller settlements and only using 
active screenings with >50% coverage as a measure could reduce 
the number of screening rounds needed to have high confidence. 
Current WHO guidelines recommend conducting three 
consecutive years of active screening with zero detections 
in a village before stopping7, therefore providing high confi-
dence of local EOT prior to cessation. Modelling suggests that 
factoring screening coverage and population size into future 
guidelines could further improve certainty that EOT is met 
before stopping and could reduce the number of zero detec-
tions required for smaller settlements if coverage is sufficient. 
Scaling these insights from the village to larger spatial scales is 
confounded by spatial correlations and reinvasion, suggesting 
an intelligent and reactive surveillance methodology is required.
Finally, there is potential for circulation of infection in animal 
reservoirs or persistence in asymptomatic individuals, which 
could lead to resurgence even after zero human reporting20.
Technical feasibility
Models predict that for some regions (e.g. Equateur, DRC) con-
tinuation of the current medical-only strategy could achieve 
local EOT by 203011; however, in other regions (particularly 
some of Bandundu, DRC) this strategy may need to be sup-
plemented with additional or improved interventions, even in 
areas likely to meet EPHP by 202012. Local EOT may be 
unsustainable without continued control due to the risk of 
reinvasion from other infected areas.
Multiple modelling approaches have shown that improve-
ments to passive surveillance, targeting active screening to 
include high-risk groups, and VC could all result in reduced 
transmission and lead to EOT by 2030 with higher probabil-
ity than the current medical-only strategy9,21. Whilst it may not 
be necessary to implement VC across all settings, modelling 
consistently finds that VC averts infections fastest amongst the 
considered strategies. Modelling also suggests that the use of 
other new technologies (i.e. new oral drugs and RDTs) could 
lead to EOT but with lower probability and slower timelines 
than VC13.
Operational feasibility
Modelling results are generally based on assumptions that the 
health system retains similar or better functionality over the 
next 10 years. Political instability, conflict, or a reduced prior-
ity for tackling the reduced number of future cases could all lead 
to less control being applied in the future. Models are therefore 
making assumptions that screening and other controls follow 
recent trends.
Ability to sustain achievement of the goal
Stopping large-scale control activities against gHAT too soon 
could be problematic for EOT. Modelling was used to explore 
potential resurgence following attainment of EPHP in Guinea22, 
concluding that the presence of animal reservoirs would 
likely lead to resurgence following cessation of screening and 
vector control, but resurgence was unlikely if transmission was 
anthroponotic. Indeed, interruption of medical interventions 
Figure 2. Probability of elimination of transmission (EOT) at the village-level based on case reporting. The positive predictive value 
(PPV) of zero case detections to assess whether local EOT has occurred is the probability of zero human infection given consecutive active 
screenings with no cases found and no passive reporting in between (for >2 screenings). Model parameterization is for Yasa Bonga and 
Mosango health zones in the Democratic Republic of the Congo. The left figure uses all active screenings with >10% coverage, while the right 
figure is restricted to screenings of >50% coverage. The yellow region indicates >90% confidence that EOT has been met locally. This figure 
has been reproduced with permission from Davis et al.19.
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in Guinea during the Ebola outbreak has shown that early 
cessation of activities in low prevalence settings can still 
lead to resurgence over three years10. In contrast, regions that 
maintained VC but stopped medical intervention observed a 
decrease in prevalence during the same time period23.
Even if an area has reached local EOT, there is a concern 
that cessation of activities could be risky if nearby places 
have on-going transmission. Modelling reinvasion of HAT in 
villages in DRC that have achieved local EOT suggests short-
term reinvasion is likely (>70%) from a single infected person, 
but less likely to cause persistent infection for ~15 years 
(<20%)19.
Considerations of costs and allocative efficiency
The burden of NTDs falls in resource-poor settings, and it is of 
utmost importance to efficiently use the resources available. 
A cost-effectiveness analysis for gHAT across settings of dif-
ferent transmission intensities has found that VC combined with 
other new technologies (diagnostics and drugs) is likely to be 
highly cost-effective in high-transmission settings (i.e. cost-
effective for WTP thresholds >$386/disability-adjusted life year 
[DALY] averted). In moderate-transmission settings this strat-
egy is only likely to be cost-effective for high WTP thresholds 
(>$1509/DALY averted), with medical-only strategies using new 
technologies likely to be preferable for lower WTP thresholds13. 
Unfortunately, cost-effectiveness in this traditional net-benefits 
framework does not always align with the goal of EOT 
by 2030, as strategies that are cost-effective (in terms of 
DALYs versus costs) may not be sufficient to meet the EOT 
goal. For example, in Sutherland et al.13, VC strategies were 
generally required to have high predicted probability of EOT by 
2030, despite having low probabilities of being cost-effective 
in moderate- or low-transmission settings.
An analysis on the affordability of gHAT intervention and 
patient financial impact estimated that the total costs of a glo-
bal control or elimination programme would be substantial 
(depending on the programme, between US$410.9 million 
and US$1.2 billion, compared to US$630.6 million for control 
activities in 2013-2020)24. Alleviation of impoverishment and 
catastrophic health expenditures for households due to gHAT 
infection can only be achieved through elimination, rather than 
control, programmes.
Risks and unknowns faced by gHAT elimination 
programmes
A more complete review of key factors that may impact the 
EOT goal is given by Büscher et al.20. Here, insights arising 
from modelling-based studies are discussed.
Systematic non-participation in screening
Several modelling studies suggest that there is systematic non-
participation in active screening, with high-risk individuals 
less likely to participate; the models without this heterogene-
ity were unable to match the observed longitudinal patterns of 
cases across different regions5,6. More detailed data on age and 
gender of screening participants and gHAT cases could help 
better elucidate key groups in the population most responsible 
for transmission.
Animal reservoirs
Although prevalence of gHAT infection in animals is nonzero, 
estimates are uncertain and the role of infected animals in 
onward transmission is unclear20. One modelling study using 
point prevalence data from animals in Cameroon suggested 
that animals constitute a possible transmission reservoir, imply-
ing that control targeting only human cases would be unable 
to eliminate gHAT due to persistence in animals25, whereas 
modelling using longitudinal human data (Guinea, DRC, 
Chad) suggest that there is comparable statistical support for 
models with and without an animal reservoir5,6,22. However, ani-
mals are unlikely to be able to sustain transmission on their 
own in Chad5.
Modelling suggests that VC, including spraying livestock, 
would reduce any possible transmission from animals, although 
pockets of sustained transmission could occur away from 
human activities26.
Asymptomatic reservoirs
Asymptomatic infections in humans have been considered in 
a few transmission models. In some9,21, the role of these infec-
tions in maintaining transmission or causing resurgence was 
unclear, although one modelling study using data from Guinea 
found both asymptomatic and clinical human infections were 
necessary for gHAT to persist (assuming no animal reservoir) 
and concluded that passive surveillance alone was not 
sufficient for gHAT monitoring in the approach to elimination27.
Movement
So far, little attention has been paid to the movement of peo-
ple in the modelling literature on gHAT; however, this may be 
important in areas that recently achieved disease-free status. 
Particular regions of concern would include formally endemic 
areas with both high influxes of refugees/internally displaced 
people and limited surveillance.
Immediate priorities
Table 2 highlights a list of priority questions for modellers 
that are of relevance for the 2030 EOT goal for gHAT arising 
from discussions between modellers and WHO.
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Table 2. Immediate priorities for modelling for gambiense human African trypanosomiasis (gHAT).
Priority issue / question identified by WHO during 
this meeting
How can modelling address this?
Probability of interrupted transmission: 
Can existing mathematical models be used to define 
the probability of interruption of gHAT transmission in 
regions where no cases have been detected?
Using historic data, and assumptions on current passive surveillance, models can 
be generated that capture the observed dynamics at regional foci and calculate 
the probability (PPV) of interrupted transmission given that no cases have been 
reported for different periods of time.
Reactive screening: 
How does a reactive screening strategy compare to 
active screening and passive detection, or passive 
detection alone in terms of:
- reduction of transmission (amount and timescales)? 
- case reporting?
Modelers can develop/refine modelling of current active and passive strategies to 
extend to simulate a reactive screening strategy. 
- The spatial scale considered will impact results. 
- Reactive strategies can and should be included in cost predictions and cost-
effectiveness analyses
Animal reservoir: 
- What do we know about their role in transmitting 
disease? 
- How could an animal reservoir affect the 2030 
target?
Some modelling has already explored possible animal reservoirs. Modelers can 
continue to explore: 
- Whether there are signals of animal reservoirs by assessing human case data alone 
- If there is any support for these models, to assess the relative contribution of animals 
to transmission, and what impact this could have on timescales to achieve EOT 
- To include animals in a village-scale model framework (to assess PPV of zero 
case detections in active screening on EOT) 
- To make estimates more robust by fitting to human and animal data (if available) 
- To assess implications of animal reservoirs in decision analyses between 
interventions
Asymptomatics: 
- Can we estimate potential number of 
asymptomatics? E.g. for one detected case, how 
many go undetected? 
- How likely are asymptomatics to infect others? 
- What do we know about their role in (maintaining) 
transmission?
- Existing modelling frameworks can be adapted to include potential 
asymptomatics (including self-cure or skin infections) 
- Sensitivity analysis and/or matching to data (if available) could estimate possible 
numbers of asymptomatics, relative contribution to transmission, infection 
timescales, and relative infectivity. Lack of data may lead to large confidence 
intervals 
- Modelers can evaluate the effectiveness of different strategy types in models with 
and without asymptomatic people - e.g. would we select the same intervention 
strategy if asymptomatics play a substantial role in transmission?
Spatial prediction: 
Support defining areas that should be screened, 
where there is potential of transmission. Similarly, 
can we rule out certain areas?
- A tsetse absence model could be used to assess regions which are unlikely to 
have gHAT due to unsuitable habitat. 
- This can be used to explore the joint distribution of the active and passive 
surveillance data and to look for factors/variables which could predict the 
underlying variation and probability of reporting. 
- It may be possible to include a range of factors into these predictions including 
changing population distribution and land-use.
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College of Engineering, Mathematics and Physical Sciences, University of Exeter, Penryn, UK
This open letter provides an overview of the use of mathematical modelling of gHAT and its uses in
support of the WHO’s target of global elimination of transmission by 2030. Coming from a modelling
background but with little knowledge of gHAT I read this letter with much interest. However, what I feel is
currently lacking is a bit more detail and structure regarding the models and their predictions themselves.
That is, from the article it is clear that various models have been developed and that they have been
applied to answer slightly different gHAT-related questions. What is not clear is what types of models
have been used for what questions, where do models generally agree or disagree, what are crucial
knowledge gaps highlighted by the these exercises, and what is the direction that models should be
heading to support local and global elimination efforts. I believe that much of this could be achieved
simply by re-organisation/restructuring, making the sections more focused and less overlapping. For
example, the problems of a potential animal reservoirs or asymptomatic infections come up more than
once, the same with screening/diagnostics. Personally I would focus on just a few key obstacles,
important aspects of gHAT epidemiology/elimination, or intervention measures, detailing the problem and
then illustrating what modelling has found and/or how it can be used in the future. Also, the authors
mention in the Abstract that accounting for uncertainties and stochastic effects is very important, which I
fully agree with, especially as one approaches disease elimination scenarios. However, I was missing the
discussion on this in the text; are none of the approaches developed so far stochastic/deal with
uncertainty? Given its importance I would suggest that the authors could maybe dedicating a separate
(sub-)section on this?
 
More specific comments:
Background, second paragraph: maybe this is a bit negative but saying that 963 cases suggests
that the first indication has been greatly surpassed the goal of getting it below 2000 is a bit of an
exaggeration; to me this suggests things are on target
 
Modelling insights from [...], first paragraph: it is not immediately obvious how staged gHAT case
data can provide substantial information on the effectiveness of surveillance; more detail on this
would be welcome
 
Table 1: the question ‘is the new target technical feasible [...]’ is answered by ‘yes’; but the next row
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Table 1: the question ‘is the new target technical feasible [...]’ is answered by ‘yes’; but the next row
goes into ‘if not, what is required’ - given that the first answer is yes, do we need this then? Or is the
answer not really ‘yes’
 
EOT before zero reporting: what are ‘algorithms’ with 99.9% specificity?
 
Zero reporting but not EOT: this seems to me like a two-part problem, the first is general
under-reporting, and the other long periods of asymptomatic infections; would it be worth making
this distinction?
 
Zero reporting but not EOT, second paragraph: replace ‘replaying’ with ‘simulating’
 
Technical feasibility: explain why the strategy could achieve local EOT in some regions but not in
others
 
Ability to sustain achievement [...]: it seems like the issue about the potential animal reservoir is
slightly controversial, i.e. what’s the evidence for or against?
 
Ability to sustain achievement [...], last paragraph: why is reintroduction less likely to cause
persistent infections? Presumably control programs would stop after elimination has been
achieved?
 
Asymptomatic reservoirs: this is a clear example where it would be good to have more of an overall
discussion on where models agree, where they differ and why.
 
Table 2: do you need the second column, or would it be possible to have this table just
listing/detailing (top priority) questions that can be addressed/answered with modelling? Personally
I find that the ‘how’ is not that important, especially as no other model details and assumptions are
being discussed here 
Overall I think that this is an important piece of work highlighting the uses of mathematical models in
public health, and a little more structured and focused approach would make it even better.
Is the rationale for the Open Letter provided in sufficient detail?
Yes
Does the article adequately reference differing views and opinions?
Yes
Are all factual statements correct, and are statements and arguments made adequately
supported by citations?
Yes
Is the Open Letter written in accessible language?
Yes
Where applicable, are recommendations and next steps explained clearly for others to follow?
Yes
 No competing interests were disclosed.Competing Interests:
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I confirm that I have read this submission and believe that I have an appropriate level of
expertise to confirm that it is of an acceptable scientific standard, however I have significant
reservations, as outlined above.
 29 October 2019Reviewer Report
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© 2019 Barrett M. This is an open access peer review report distributed under the terms of the Creative Commons
, which permits unrestricted use, distribution, and reproduction in any medium, provided the originalAttribution License
work is properly cited.
 Michael P. Barrett
Wellcome Centre for Integrative Parasitology, Institute of Infection, Immunity and Inflammation, University
of Glasgow, Glasgow, UK
The open letter is a clear overview of modelling efforts tracing the road to elimination of gambiense HAT.
Background: Paragraph 1, line 6:  note parasites can cross the BBB before establishing
themselves there to make stage 2 infection, so please change to reflect that.
 
Line 11: After 37,385 - add the word "reported" before cases.
 
Paragraph 2, line 4:  2,000 (add the comma). Line 9:  Also add a comma to 1,419.
 
Paragraph 3, line 10-11: place commas around "and likelihood of reaching".
 
Table 1, point 5: I am not certain that "existing diagnostics are likely sufficient". If skin parasites are
not sustaining serum antibody titres, and also if the standard antigens used in current tests are not
present in a cohort of residual parasites it is likely the diagnostics will become ever less sensitive.
 
On page 4: the reference to the trypanolysis test which purports 100% specificity is, I think, equally
vulnerable to loss of sensitivity in cases where parasites not expressing antigens central to this test
are in circulation.
 
On page 5: Second paragraph points to the potential of animal reservoirs and asymptomatic
individuals. However, the downward trend appears to have been following predictions quite nicely
(where these refugia are not considered). Does the modelling so far, therefore, rule out a
significant impact of the animal reservoir and asymptomatic patients, or does incidence have to get
even lower before the problem will become manifest?
 
Page 5. section Operational feasibility: It is stated that "Models are therefore making assumptions
that screening and other controls follow recent trends." Can't the models themselves be used now
to predict what happens in the event of different removal of control scenarios?
 
Page 6, Last paragraph before the "Risks and unknowns....." section: This covers estimate of cost
of control based on the Sutherland and Tediosi work. Clearly these estimates could have a large
impact on policy decisions. Can the authors offer an opinion on how robust they consider those
findings (in the light of modelling predictions?)
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findings (in the light of modelling predictions?)
 
Page 6, column 2, section on "Movement", line 4:  "formally" should be "formerly"
 
References, reference 1: More information needed to access.
 
Some references e.g.  4, 12,14, 15, 20, 21, 26 are using capital first letters for individual words in
the title, while others are not.
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Yes
 No competing interests were disclosed.Competing Interests:
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